Your browser doesn't support javascript.
loading
Theranostics - a sure cure for cancer after 100 years?
Song, Yangmeihui; Zou, Jianhua; Castellanos, E Alejandro; Matsuura, Naomi; Ronald, John A; Shuhendler, Adam; Weber, Wolfgang A; Gilad, Assaf A; Müller, Cristina; Witney, Timothy H; Chen, Xiaoyuan.
Afiliación
  • Song Y; Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, 81675, Germany.
  • Zou J; Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 43000, China.
  • Castellanos EA; Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, Singapore, 119074, Singapore.
  • Matsuura N; Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore.
  • Ronald JA; Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
  • Shuhendler A; Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research (A*STAR), 61 Biopolis Drive, Proteos, Singapore, 138673, Singapore.
  • Weber WA; Department of Biomedical Engineering, Michigan State University, East Lansing, MI, USA.
  • Gilad AA; Institute of Biomedical Engineering, University of Toronto, Toronto, ON, Canada.
  • Müller C; Department of Materials Science & Engineering, University of Toronto, Toronto, ON, Canada.
  • Witney TH; Department of Medical Imaging, University of Toronto, Toronto, ON, Canada.
  • Chen X; Imaging Laboratories, Department of Medical Biophysics, Robarts Research Institute, University of Western Ontario, London, ON, Canada.
Theranostics ; 14(6): 2464-2488, 2024.
Article en En | MEDLINE | ID: mdl-38646648
ABSTRACT
Cancer has remained a formidable challenge in medicine and has claimed an enormous number of lives worldwide. Theranostics, combining diagnostic methods with personalized therapeutic approaches, shows huge potential to advance the battle against cancer. This review aims to provide an overview of theranostics in oncology exploring its history, current advances, challenges, and prospects. We present the fundamental evolution of theranostics from radiotherapeutics, cellular therapeutics, and nanotherapeutics, showcasing critical milestones in the last decade. From the early concept of targeted drug delivery to the emergence of personalized medicine, theranostics has benefited from advances in imaging technologies, molecular biology, and nanomedicine. Furthermore, we emphasize pertinent illustrations showcasing that revolutionary strategies in cancer management enhance diagnostic accuracy and provide targeted therapies customized for individual patients, thereby facilitating the implementation of personalized medicine. Finally, we describe future perspectives on current challenges, emerging topics, and advances in the field.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Medicina de Precisión / Nanomedicina Teranóstica / Neoplasias Límite: Animals / Humans Idioma: En Revista: Theranostics Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Medicina de Precisión / Nanomedicina Teranóstica / Neoplasias Límite: Animals / Humans Idioma: En Revista: Theranostics Año: 2024 Tipo del documento: Article País de afiliación: Alemania